Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

被引:0
|
作者
Kannie Chim
Sharon X Xie
Carrie T Stricker
Qing S Li
Robert Gross
John T Farrar
Angela DeMichele
Jun J Mao
机构
[1] University of Pennsylvania,Department of Family Medicine and Community Health
[2] Perelman School of Medicine at the University of Pennsylvania,Center for Clinical Epidemiology and Biostatistics
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine
来源
BMC Cancer | / 13卷
关键词
Aromatase inhibitor; Joint pain; Adherence; Adverse effects; Musculoskeletal; Breast cancer; Pain diagnosis; Pain management; Survivorship;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
    Chim, Kannie
    Xie, Sharon X.
    Stricker, Carrie T.
    Li, Qing S.
    Gross, Robert
    Farrar, John T.
    DeMichele, Angela
    Mao, Jun J.
    [J]. BMC CANCER, 2013, 13
  • [2] Baseline joint pain predicts severity of subsequent joint symptoms in women initiating aromatase inhibitors for early stage breast cancer
    Baer, Lea
    Crew, Katherine D.
    Awad, Danielle
    Kalinsky, Kevin
    Maurer, Matt
    Hershman, Dawn L.
    [J]. CANCER RESEARCH, 2015, 75
  • [3] Understanding premature discontinuation of aromatase inhibitor (AI) therapy in postmenopausal breast cancer survivors
    Stricker, C. T.
    Palmer, S. C.
    DeMichele, A.
    Mao, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Joint pain and falls among women with breast cancer on aromatase inhibitors
    Basal, Coby
    Vertosick, Emily
    Gillis, Theresa A.
    Li, Qing
    Bao, Ting
    Vickers, Andrew
    Mao, Jun J.
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (06) : 2195 - 2202
  • [5] Joint pain and falls among women with breast cancer on aromatase inhibitors
    Coby Basal
    Emily Vertosick
    Theresa A. Gillis
    Qing Li
    Ting Bao
    Andrew Vickers
    Jun J. Mao
    [J]. Supportive Care in Cancer, 2019, 27 : 2195 - 2202
  • [6] Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors
    Irwin, Melinda
    Cartmel, Brenda
    Ercolano, Elizabeth
    Fiellin, Martha
    Rothbard, Marianna
    Capozza, Scott
    Zhou, Yang
    Schmitz, Kathryn
    Ligibel, Jennifer A.
    Hershman, Dawn L.
    Neogi, Tuhina
    Gross, Cary P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
    Chlebowski, Rowan T.
    Schottinger, Joanne E.
    Shi, Jiaxiao
    Chung, Joanie
    Haque, Reina
    [J]. CANCER, 2015, 121 (13) : 2147 - 2155
  • [8] Longitudinal Joint Pain in Postmenopausal Women with Early Breast Cancer Taking Aromatase Inhibitors
    Castel, Liana D.
    Hartmann, Katherine
    Deppen, Stephen
    Mayer, Ingrid
    Johnson, David
    Boomershine, Chad
    Abramson, Vandana G.
    Chakravarthy, Anuradha
    McLellan, Sarah Elizabeth
    Friedman, Debra L.
    Cella, David
    [J]. QUALITY OF LIFE RESEARCH, 2010, 19 : 44 - 45
  • [9] Joint pain and physical activity among breast cancer survivors on aromatase inhibitor therapy.
    Nyrop, Kirsten A.
    Muss, Hyman
    Hackney, Betsy
    Clevalend, Rebecca
    Callahan, Leigh F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Managing Aromatase Inhibitors in Breast Cancer Survivors: Not Just for Oncologists
    Files, Julia A.
    Ko, Marcia G.
    Pruthi, Sandhya
    [J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 560 - 566